New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 10, 2014
11:00 EDTAG, TTS, MEMP, MEOH, DRWI, CBS, EXK, CBSOHigh option volume stocks
High option volume stocks: CBS MEMP EWT CBSO DRWI TRW TTS EXK MEOH AG
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2015
17:35 EDTEXKEndeavour Silver announces at-the-market offering of up to $16.5M
Subscribe for More Information
November 16, 2015
07:01 EDTAGFirst Majestic reports Q3 EPS (1c), consensus (4c)
Subscribe for More Information
November 13, 2015
11:38 EDTCBSBox Office Battle: 'Spectre,' 'The Peanuts Movie' expected to remain on top
Sony's (SNE) "Spectre," starring Daniel Craig as James Bond, is again expected to top the box office in its second weekend at theaters, with an estimated domestic gross in the $30.3M-$32.4M range. Fox's (FOX, FOXA) G-rated family film "The Peanuts Movie," starring a 3D-animated Charlie Brown, is again likely to come in second, predicted to earn an additional $28.7M. Newcomer "The 33," a drama retelling the true story of the Chilean miners that were trapped underground in 2010, is expected to open between $5.5M-$10M in 2,400 theaters. "The 33" is being distributed in North America by Time Warner's (TWX) Warner Bros. Pictures, and in Latin America by Fox's 20th Century Fox. Holiday dramedy "Love the Coopers," starring John Goodman and Diane Keaton, is estimated to open in the $5.2M-$8M range. "Love the Coopers" is being released in 2,603 theaters by Lionsgate (LGF) and CBS's (CBS) CBS Films. Fox's "The Martian," which opened on October 2, is predicted to earn an additional $6M-$6.8M. Other publicly traded companies involved in filmmaking include Comcast (CMCSA, CMCSK), Disney (DIS), and Viacom (VIA, VIAB).
11:33 EDTCBSStocks with call strike movement; CBS CMG
Subscribe for More Information
10:53 EDTCBSCBS management to meet with Barrington
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use